Exchange: OTC·Updated 11:35 AM EDT

ENDV Endonovo Therapeutics Inc

$0.0001
$0.00
(0.00%)
Today
Mkt Cap$180,756.00
Vol500,000.00

About ENDV

Endonovo Therapeutics, Inc. is a biotechnology company, which engages in the development, manufacture, and distribution of medical devices focused on the rapid healing of wounds and reduction of pain, edema, and inflammation on and in the human body. Its technology and products include Electroceuticals, EFECT Trial, and SofPulse Electroceutical Therapy. The company was founded in November 2008 and is headquartered in Woodland Hills, CA.
50

Neutral Sentiment

How do you feel about ENDV?

Advertisement|Remove ads.